Short answer
CABOT CORP (CBT) filed an 8-K current report with the SEC on July 30, 2026 reporting Item 5.02 (Departure/Election of Directors or Officers), Item 7.01 (Regulation FD Disclosure), Item EX-99.1 (Exhibit EX-99.1). CEO transition effective October 1, 2026: Erica McLaughlin succeeds retiring Sean Keohane.
CABOT CORP 8-K event analysis
AI summary of each reported item and its exhibits
Item 5.02 · Departure/Election of Directors or Officers
- CEO transition effective October 1, 2026: Erica McLaughlin succeeds retiring Sean Keohane
- McLaughlin joins the Board and Executive Committee, with her director term expiring at the 2029 Annual Meeting
- CFO search underway after McLaughlin’s departure from the executive vice president role
- McLaughlin’s base salary rises to $910,000, with fiscal 2027 short-term incentive target increasing to 120% of salary
- Keohane remains a non-executive employee through December 31, 2026, preserving transition support while equity awards receive retirement vesting treatment
Item 7.01 · Regulation FD Disclosure
- Management-transition press release issued July 30, 2026
- Exhibit 99.1 contains the substantive transition details
- Leadership change may affect strategic execution and investor expectations
Item EX-99.1 · Exhibit EX-99.1
- CEO Sean Keohane retires and leaves Cabot’s board effective September 30, 2026 after serving as CEO since 2016
- CFO and Strategy Head Erica McLaughlin becomes President and CEO October 1, 2026, signaling internal succession and strategic continuity
- CFO search underway, creating an interim execution and investor-relations transition risk
- Keohane remains as advisor through calendar year-end 2026 to support leadership handover
- Key risks include management-transition execution, battery-materials growth, raw-material volatility, tariffs, and macroeconomic conditions
Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean
Other CABOT CORP 8-K filings
Get the next CBT 8-K as it lands
Follow CBT for push alerts, or ask the research agent what this filing means.